Literature DB >> 8344721

Sharing of an HLA-B27-restricted H-Y antigen between rat and mouse.

W A Simmons1, J D Taurog, R E Hammer, M Breban.   

Abstract

The purpose of this work was twofold: 1) to learn whether rats transgenic for HLA-B27 and the human beta 2-microglobulin gene HB2M can mount B27-restricted cytolytic T lymphocyte (CTL) responses to the male H-Y antigen, and 2) to learn whether such CTLs would recognize both rat and mouse H-Y in the context of HLA-B27. Female rats of the B27/HB2M transgenic line 21-4L were primed in vivo with cells from males of the same line. CTL effectors were generated from lymph node cells of these females following culture with irradiated antigen-presenting cells from either male 21-4L rats or male mice of the B27/HB2M transgenic 56-3 line. The CTLs showed male-specific, B27-specific lysis of both rat and mouse targets. Lysis of B27 targets was inhibitable by monoclonal antibodies specific for B27 or rat CD8. Specific lysis of male B27 rat and mouse targets was inhibitable equally by either rat or mouse male B27 cold targets, but not significantly by female or nontransgenic cold targets. The B27-restricted CTLs neither recognized nor were inhibited by B27+ or B27- male or female human targets. These results demonstrate that CD8+, B27-restricted, anti-H-Y CTLs recognize an evolutionarily conserved H-Y peptide antigen in both rats and mice. In addition, they establish the transgenic rat as a model system for examining the T-cell response to antigen presented by class I HLA molecules.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8344721     DOI: 10.1007/bf00210477

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  33 in total

Review 1.  What are minor histocompatibility loci? A new look at an old question.

Authors:  D C Roopenian
Journal:  Immunol Today       Date:  1992-01

2.  Specificity of antigen processing for MHC class I restricted presentation is conserved between mouse and man.

Authors:  K Falk; O Rötzschke; H G Rammensee
Journal:  Eur J Immunol       Date:  1992-05       Impact factor: 5.532

Review 3.  Guilt by association: HLA-B27 and ankylosing spondylitis.

Authors:  R Benjamin; P Parham
Journal:  Immunol Today       Date:  1990-04

4.  Y-antigen killing by T cells of women is restricted by HLA.

Authors:  E Goulmy; A Termijtelen; B A Bradley; J J van Rood
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

5.  Major histocompatibility complex antigens in rat kidney, ureter, and bladder. Localization with monoclonal antibodies and demonstration of Ia-positive dendritic cells.

Authors:  D N Hart; J W Fabre
Journal:  Transplantation       Date:  1981-05       Impact factor: 4.939

6.  Induction of interleukin 1 secretion and of tumoricidal activity in macrophages are not closely related phenomena.

Authors:  R Keller; R Keist
Journal:  Eur J Immunol       Date:  1987-11       Impact factor: 5.532

7.  Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression.

Authors:  J D Taurog; S D Maika; W A Simmons; M Breban; R E Hammer
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

8.  The cellular basis of adjuvant arthritis. I. Enhancement of cell-mediated passive transfer by concanavalin A and by immunosuppressive pretreatment of the recipient.

Authors:  J D Taurog; G P Sandberg; M L Mahowald
Journal:  Cell Immunol       Date:  1983-02-01       Impact factor: 4.868

9.  Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.

Authors:  K Ozato; D H Sachs
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

10.  Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.

Authors:  K Ozato; N Mayer; D H Sachs
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

View more
  5 in total

Review 1.  Novel experimental approaches in the study of the immunopathology in inflammatory bowel disease.

Authors:  J Reimann; A Rudolphi; M H Claesson
Journal:  J Mol Med (Berl)       Date:  1995-03       Impact factor: 4.599

2.  Cytotoxic T-cell-mediated response against Yersinia pseudotuberculosis in HLA-B27 transgenic rat.

Authors:  G Falgarone; H S Blanchard; B Riot; M Simonet; M Breban
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

Review 3.  Experimental spondyloarthropathy in HLA-B27 transgenic rats.

Authors:  J D Taurog; R E Hammer
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

4.  Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment.

Authors:  M Breban; R E Hammer; J A Richardson; J D Taurog
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

5.  The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats.

Authors:  M Zhou; A Sayad; W A Simmons; R C Jones; S D Maika; N Satumtira; M L Dorris; S J Gaskell; R S Bordoli; R B Sartor; C A Slaughter; J A Richardson; R E Hammer; J D Taurog
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.